Potassium Phosphates (Hospira, Inc.)


Welcome to the PulseAid listing for the Potassium Phosphates drug offered from Hospira, Inc.. This Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: POTASSIUM PHOSPHATE, MONOBASIC and POTASSIUM PHOSPHATE, DIBASIC
SUBSTANCE NAME: POTASSIUM PHOSPHATE, MONOBASIC; DIBASIC POTASSIUM PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 1984-09-17
END MARKETING DATE: 0000-00-00


Potassium Phosphates HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPotassium Phosphates from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 224; 236(mg/mL; mg/mL)
START MARKETING DATE: 1984-09-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-7295_a5a805c5-d00a-43c3-bc2b-c87caf9f3d89
PRODUCT NDC: 0409-7295
APPLICATION NUMBER:

Other POTASSIUM PHOSPHATE, MONOBASIC; DIBASIC POTASSIUM PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.Potassium Phosphates